Inventor · Waltham, MA, US

Bin Yang

38Patents
7h-index
83Co-inventors
72Inventor score

Filing activity: Apr 8, 2002 → Jul 29, 2024

Most-cited inventions

PatentTitleAreaCited byStatus
US6653443B2 Multimerization of HIV-1 Vif protein as a therapeutic target Emerging Cross-Sectional Technologies 47 Expired
US9778155B2 Methods for phenotyping of intact whole tissues Physics 45 Active
US8729017B2 Glucagon/GLP-1 receptor co-agonists Physics 24 Active
US7875444B2 Lignin blockers and uses thereof Emerging Cross-Sectional Technologies 18 Expired
US8981047B2 Glucagon antagonists Human Necessities 16 Active
US8980830B2 Peptide compounds exhibiting glucagon antagonist and GLP-1 agonist activity Human Necessities 15 Active
US7604967B2 Lignin-blocking treatment of biomass and uses thereof Emerging Cross-Sectional Technologies 13 Expired
US9778154B2 Methods for phenotyping of intact whole tissues Physics 6 Active
US11746120B2 Stat degraders and uses thereof Human Necessities 3 Active
US8461170B2 Chemical compounds Chemistry; Metallurgy 3 Active
US7981903B2 2-[2-{phenylamino}-1H-pyrrolo[2,3-D]pyrimidin-4-yl)amino] benzamide derivatives as IGF-1R inhibitors for the treatment of cancer Chemistry; Metallurgy 2 Active
US8580541B2 Lignin blockers and uses thereof Emerging Cross-Sectional Technologies 2 Active
US11485750B1 STAT degraders and uses thereof Human Necessities 2 Active
US9783592B2 Glucagon superfamily peptides exhibiting nuclear hormone receptor activity Chemistry; Metallurgy 2 Active
US10131663B2 Chemical compounds Human Necessities 1 Active
US7226741B2 Multimerization of HIV-1 Vif protein as a therapeutic target Emerging Cross-Sectional Technologies 1 Expired
US7498138B2 Multimerization of HIV-1 Vif protein as a therapeutic target Emerging Cross-Sectional Technologies 1 Active
US8338573B2 Crystal structure of CD147 extracellular region and use thereof Emerging Cross-Sectional Technologies 1 Active
US10196665B2 Cell culture medium and methods for enhancing recombinant antibody purity Chemistry; Metallurgy 1 Active
US9309301B2 Glucagon/GLP-1 receptor co-agonists Physics 1 Active
US10568892B2 Cycloartane tetracyclic triterpenoid compound, preparation method therefor and use thereof Human Necessities 0 Active
US10131889B1 Candida antarctica lipase B mutant, and methods for making and using the same Chemistry; Metallurgy 0 Active
US12194004B2 Nano-delivery carrier for targeted tumor administration and application thereof Human Necessities 0 Active
US9127088B2 Glucagon superfamily peptides exhibiting nuclear hormone receptor activity Chemistry; Metallurgy 0 Active
US10125135B2 Chemical compounds Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.